MAPT and Alzheimer disease: Abnormal acetylation of tau at specific residues has been reported in AD and related tauopathies associated with aggregation (Min et al. 2010; Cohen et al. 2011; Irwin et al. 2012; Tracy et al. 2016; Wesseling et al. 2020).